| High speed of fork progression induces DNA replication stress and genomic instability A Maya-Mendoza, P Moudry, JM Merchut-Maya, MH Lee, R Strauss, ... Nature 559 (7713), 279-284, 2018 | 519 | 2018 |
| Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14 H Wang, ZY Li, Y Liu, J Persson, I Beyer, T Möller, D Koyuncu, ... Nature medicine 17 (1), 96-104, 2011 | 501 | 2011 |
| Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity R Strauss, ZY Li, Y Liu, I Beyer, J Persson, P Sova, T Möller, S Pesonen, ... PloS one 6 (1), e16186, 2011 | 256 | 2011 |
| Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis P Sova, Q Feng, G Geiss, T Wood, R Strauss, V Rudolf, A Lieber, N Kiviat Cancer Epidemiology Biomarkers & Prevention 15 (1), 114-123, 2006 | 212 | 2006 |
| Strategies to increase drug penetration in solid tumors IK Choi, R Strauss, M Richter, CO Yun, A Lieber Frontiers in oncology 3, 193, 2013 | 198 | 2013 |
| A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells S Tuve, H Wang, C Ware, Y Liu, A Gaggar, K Bernt, D Shayakhmetov, ... Journal of virology 80 (24), 12109-12120, 2006 | 185 | 2006 |
| Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein R Strauss, A Hüser, S Ni, S Tuve, N Kiviat, PS Sow, C Hofmann, A Lieber Molecular Therapy 15 (1), 193-202, 2007 | 152 | 2007 |
| Combination of tumor Site–Located CTL-Associated antigen-4 blockade and systemic regulatory T-cell depletion induces Tumor-Destructive immune responses S Tuve, BM Chen, Y Liu, TL Cheng, P Touré, PS Sow, Q Feng, N Kiviat, ... Cancer research 67 (12), 5929-5939, 2007 | 121 | 2007 |
| Systems‐based practice: the sixth core competency PL Dyne, RW Strauss, S Rinnert Academic Emergency Medicine 9 (11), 1270-1277, 2002 | 106 | 2002 |
| Epithelial junction opener JO-1 improves monoclonal antibody therapy of cancer I Beyer, R van Rensburg, R Strauss, ZY Li, H Wang, J Persson, R Yumul, ... Cancer research 71 (22), 7080-7090, 2011 | 96 | 2011 |
| TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity P Moudry, K Watanabe, KM Wolanin, J Bartkova, IE Wassing, S Watanabe, ... Journal of Cell Biology 212 (3), 281-288, 2016 | 92 | 2016 |
| Comparison of adenoviruses from species B, C, E, and F after intravenous delivery D Stone, Y Liu, ZY Li, S Tuve, R Strauss, A Lieber Molecular Therapy 15 (12), 2146-2153, 2007 | 88 | 2007 |
| Radiotherapy-induced plasticity of prostate cancer mobilizes stem-like non-adherent, Erk signaling-dependent cells L Kyjacova, S Hubackova, K Krejcikova, R Strauss, H Hanzlikova, ... Cell Death & Differentiation 22 (6), 898-911, 2015 | 80 | 2015 |
| Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses R Strauss, P Sova, Y Liu, ZY Li, S Tuve, D Pritchard, P Brinkkoetter, ... Cancer research 69 (12), 5115-5125, 2009 | 78 | 2009 |
| Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting S Ni, A Gaggar, N Di Paolo, ZY Li, Y Liu, R Strauss, P Sova, J Morihara, ... Cancer gene therapy 13 (12), 1072-1081, 2006 | 69 | 2006 |
| In situ adenovirus vaccination engages T effector cells against cancer S Tuve, Y Liu, K Tragoolpua, JD Jacobs, RC Yumul, ZY Li, R Strauss, ... Vaccine 27 (31), 4225-4239, 2009 | 65 | 2009 |
| Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination N DiPaolo, S Ni, A Gaggar, R Strauss, S Tuve, ZY Li, D Stone, ... Molecular Therapy 13 (4), 756-765, 2006 | 62 | 2006 |
| Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress K Chroma, M Mistrik, P Moudry, J Gursky, M Liptay, R Strauss, Z Skrott, ... Oncogene 36 (17), 2405-2422, 2017 | 52 | 2017 |
| Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer R Strauss, P Hamerlik, A Lieber, J Bartek Molecular Therapy 20 (5), 887-897, 2012 | 45 | 2012 |
| Antihistamines and ovarian cancer survival: nationwide cohort study and in vitro cell viability assay F Verdoodt, C Dehlendorff, M Jäättelä, R Strauss, A Pottegård, J Hallas, ... JNCI: Journal of the National Cancer Institute 112 (9), 964-967, 2020 | 36 | 2020 |